Merck and Transylvanian Institute of Neuroscience Cooperate on Brain-Inspired Artificial Intelligence
Merck, a leading science and technology company, announced a three-year collaboration with the Transylvanian Institute...
Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19...
Sanofi and GSK announced the initiation of a new Phase 2 study with 720 volunteers...
RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced agreements with Cosmo Pharmaceuticals NV to manufacture...
AstraZeneca COVID-19 vaccine authorised for emergency use by the World Health Organization
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization...
HKSTP and AstraZeneca Launch Co-incubation Programme for Biomedical Startups to Develop Made in HK...
AstraZeneca and the Hong Kong Science and Technology Parks Corporation (HKSTP) have launched a co-incubation...
Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research
Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable,...
AstraZeneca’s Forxiga approved in China for heart failure
AstraZeneca’s Forxiga has been approved in China to reduce the risk of cardiovascular (CV) death...
Bayer receives approval for Nubeqa in China for the treatment of men with non-metastatic...
The Chinese National Medical Products Administration (NMPA) has approved Nubeqa for the treatment of patients...
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19...
Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data...
